SCOTTISH scientists say they have identified a link between strains of a malaria parasite, potentially paving the way for a life-saving vaccine.
A key protein common to different types of malaria parasite is said to have been uncovered, and laboratory tests show antibodies that target the protein are effective in blocking the mechanisms that cause the disease.
Researchers at Edinburgh University are now appealing to the pharmaceutical and biotechnology industries to help them apply the findings and bring forward the next generation of malaria drug or vaccine.
In Africa a child dies, on average, every minute from malaria, according to the World Health Organisation.
The Democratic Republic of Congo and Nigeria account for at least 40% of the estimated malaria deaths globally.
The protein identified by researchers binds to red blood cells using its "sticky" structure and forms clusters, known as rosettes, that can block blood vessels in the brain and lead to cerebral malaria, the most lethal form of the disease.
Once injected into the blood by the mosquito, malaria parasites alter protein molecules on their surfaces to evade detection by the human immune system.
Normally these surface proteins are poor targets for treatments or vaccines because, until now, they have differed greatly between the various malaria parasite strains.
However, researchers found the surface proteins of rosette-forming parasites share similarities that may allow them to act as a target for new treatments to block progress of the disease.
Professor Alexandra Rowe, from Edinburgh University's school of biological sciences, said: "We were aware the blood cell rosettes were apparent in many cases of life-threatening malaria, so we looked at rosette-forming parasites and found a common factor that could be targeted with antibodies. With this research yielding positive results, investigations into the viability of new treatments and vaccines to eradicate the formation of rosettes and prevent instances of life-threatening malaria are now under way."
Scientists collaborated with researchers from Cameroon, Mali, Kenya and The Gambia to test their antibodies against parasites collected from patients.
Wendy Nicholson, from the university's commercial arm, Edinburgh Research and Innovation, said: "The quest now is to stimulate pharmaceutical com-panies into the funding of early-stage vaccine and drug development programmes that offer genuine hope in halting the alarming death rate prevalence of this disease."
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules hereComments are closed on this article